
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?
Brandon J. Aubrey, Gemma L. Kelly, Ana Janic, et al.
Cell Death and Differentiation (2017) Vol. 25, Iss. 1, pp. 104-113
Open Access | Times Cited: 1081
Brandon J. Aubrey, Gemma L. Kelly, Ana Janic, et al.
Cell Death and Differentiation (2017) Vol. 25, Iss. 1, pp. 104-113
Open Access | Times Cited: 1081
Showing 1-25 of 1081 citing articles:
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Yanhua Mou, Jun Wang, Jinchun Wu, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 1427
Yanhua Mou, Jun Wang, Jinchun Wu, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 1427
Flavonoids in Cancer and Apoptosis
Mariam Abotaleb, Samson Mathews Samuel, Elizabeth Varghese, et al.
Cancers (2018) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 628
Mariam Abotaleb, Samson Mathews Samuel, Elizabeth Varghese, et al.
Cancers (2018) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 628
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 474
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 474
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Elham Alsahafi, Katheryn Begg, Ivano Amelio, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 438
Elham Alsahafi, Katheryn Begg, Ivano Amelio, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 438
Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death
Anna Martina Battaglia, Roberta Chirillo, Ilenia Aversa, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1505-1505
Open Access | Times Cited: 407
Anna Martina Battaglia, Roberta Chirillo, Ilenia Aversa, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1505-1505
Open Access | Times Cited: 407
Targeting p53 pathways: mechanisms, structures and advances in therapy
Haolan Wang, Ming Guo, Hudie Wei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 374
Haolan Wang, Ming Guo, Hudie Wei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 374
Genetic and biological hallmarks of colorectal cancer
Jiexi Li, Xingdi Ma, Deepavali Chakravarti, et al.
Genes & Development (2021) Vol. 35, Iss. 11-12, pp. 787-820
Open Access | Times Cited: 360
Jiexi Li, Xingdi Ma, Deepavali Chakravarti, et al.
Genes & Development (2021) Vol. 35, Iss. 11-12, pp. 787-820
Open Access | Times Cited: 360
Ferroptosis, radiotherapy, and combination therapeutic strategies
Guang Lei, Chao Mao, Yuelong Yan, et al.
Protein & Cell (2021) Vol. 12, Iss. 11, pp. 836-857
Open Access | Times Cited: 319
Guang Lei, Chao Mao, Yuelong Yan, et al.
Protein & Cell (2021) Vol. 12, Iss. 11, pp. 836-857
Open Access | Times Cited: 319
Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis
Annadurai Anandhan, Matthew Dodson, Cody J. Schmidlin, et al.
Cell chemical biology (2020) Vol. 27, Iss. 4, pp. 436-447
Open Access | Times Cited: 309
Annadurai Anandhan, Matthew Dodson, Cody J. Schmidlin, et al.
Cell chemical biology (2020) Vol. 27, Iss. 4, pp. 436-447
Open Access | Times Cited: 309
Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy
Keywan Mortezaee, Ensieh Salehi, Hanifeh Mirtavoos‐Mahyari, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 8, pp. 12537-12550
Closed Access | Times Cited: 300
Keywan Mortezaee, Ensieh Salehi, Hanifeh Mirtavoos‐Mahyari, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 8, pp. 12537-12550
Closed Access | Times Cited: 300
p53 and Tumor Suppression: It Takes a Network
Anthony M. Boutelle, Laura D. Attardi
Trends in Cell Biology (2021) Vol. 31, Iss. 4, pp. 298-310
Open Access | Times Cited: 234
Anthony M. Boutelle, Laura D. Attardi
Trends in Cell Biology (2021) Vol. 31, Iss. 4, pp. 298-310
Open Access | Times Cited: 234
Developing TRAIL/TRAIL death receptor-based cancer therapies
Xun Yuan, Ambikai Gajan, Qian Chu, et al.
Cancer and Metastasis Reviews (2018) Vol. 37, Iss. 4, pp. 733-748
Open Access | Times Cited: 212
Xun Yuan, Ambikai Gajan, Qian Chu, et al.
Cancer and Metastasis Reviews (2018) Vol. 37, Iss. 4, pp. 733-748
Open Access | Times Cited: 212
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 207
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 207
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Xiaohua Chen, Taotao Zhang, Wei Su, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 196
Xiaohua Chen, Taotao Zhang, Wei Su, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 196
Towards targeting of shared mechanisms of cancer metastasis and therapy resistance
Felix Weiß, Douglas A. Lauffenburger, Peter Friedl
Nature reviews. Cancer (2022) Vol. 22, Iss. 3, pp. 157-173
Open Access | Times Cited: 189
Felix Weiß, Douglas A. Lauffenburger, Peter Friedl
Nature reviews. Cancer (2022) Vol. 22, Iss. 3, pp. 157-173
Open Access | Times Cited: 189
Control of metabolism by p53 – Cancer and beyond
Christiaan F. Labuschagne, Fabio Zani, Karen H. Vousden
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 1, pp. 32-42
Open Access | Times Cited: 188
Christiaan F. Labuschagne, Fabio Zani, Karen H. Vousden
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 1, pp. 32-42
Open Access | Times Cited: 188
The Odyssey of Bioactive Compounds in Avocado (Persea americana) and Their Health Benefits
Deep Jyoti Bhuyan, Alsherbiny, Perera, et al.
Antioxidants (2019) Vol. 8, Iss. 10, pp. 426-426
Open Access | Times Cited: 177
Deep Jyoti Bhuyan, Alsherbiny, Perera, et al.
Antioxidants (2019) Vol. 8, Iss. 10, pp. 426-426
Open Access | Times Cited: 177
Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance
Bowen Xie, Shuangyan Wang, Nian Jiang, et al.
Cancer Letters (2018) Vol. 443, pp. 56-66
Open Access | Times Cited: 169
Bowen Xie, Shuangyan Wang, Nian Jiang, et al.
Cancer Letters (2018) Vol. 443, pp. 56-66
Open Access | Times Cited: 169
Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products
Iksen Iksen, Sutthaorn Pothongsrisit, Varisa Pongrakhananon
Molecules (2021) Vol. 26, Iss. 13, pp. 4100-4100
Open Access | Times Cited: 161
Iksen Iksen, Sutthaorn Pothongsrisit, Varisa Pongrakhananon
Molecules (2021) Vol. 26, Iss. 13, pp. 4100-4100
Open Access | Times Cited: 161
Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
Zeinab Nouri, Sajad Fakhri, Keyvan Nouri, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2276-2276
Open Access | Times Cited: 154
Zeinab Nouri, Sajad Fakhri, Keyvan Nouri, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2276-2276
Open Access | Times Cited: 154
Cuproptosis: p53-regulated metabolic cell death?
Xiong Chen, Hong Ling, Qian Hao, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 4, pp. 876-884
Open Access | Times Cited: 138
Xiong Chen, Hong Ling, Qian Hao, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 4, pp. 876-884
Open Access | Times Cited: 138
Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Qingfang Li, Yan Tie, Aqu Alu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 123
Qingfang Li, Yan Tie, Aqu Alu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 123
Predicting tumour radiosensitivity to deliver precision radiotherapy
James Price, Asmithaa Prabhakaran, Catharine West
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 2, pp. 83-98
Open Access | Times Cited: 96
James Price, Asmithaa Prabhakaran, Catharine West
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 2, pp. 83-98
Open Access | Times Cited: 96
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 93
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 93
Should mutant TP53 be targeted for cancer therapy?
Zilu Wang, Andreas Strasser, Gemma L. Kelly
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 911-920
Open Access | Times Cited: 89
Zilu Wang, Andreas Strasser, Gemma L. Kelly
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 911-920
Open Access | Times Cited: 89